当前位置:首页 - 行情中心 - 赛升药业(300485) - 财务分析 - 现金流量表

赛升药业

(300485)

  

流通市值:34.17亿  总市值:60.11亿
流通股本:2.74亿   总股本:4.82亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金228,375,313.04110,077,362.61436,907,932.47331,465,719
  收到的税费返还2,346,593.29-2,188,070.832,188,070.83
  收到其他与经营活动有关的现金288,639.15102,289.858,714,494.318,164,875.66
  经营活动现金流入小计231,010,545.48110,179,652.46447,810,497.61341,818,665.49
  购买商品、接受劳务支付的现金49,541,537.8830,634,498.7274,942,190.4167,677,042.55
  支付给职工以及为职工支付的现金38,750,125.4619,762,616.1872,426,426.9558,389,067.07
  支付的各项税费30,589,303.668,080,848.0523,896,624.0914,532,819.94
  支付其他与经营活动有关的现金82,787,678.4641,017,924.89140,571,309.9695,758,498.14
  经营活动现金流出小计201,668,645.4699,495,887.84311,836,551.41236,357,427.7
  经营活动产生的现金流量净额29,341,900.0210,683,764.62135,973,946.2105,461,237.79
二、投资活动产生的现金流量:
  收回投资收到的现金30,762,094.12-66,187,973.8636,350,077.98
  取得投资收益收到的现金5,146,725.994,903,575.0825,216,340.6514,800,880.89
  处置固定资产、无形资产和其他长期资产收回的现金净额180,000159,292.04--
  收到的其他与投资活动有关的现金490,379,143.52465,945,800658,027,917.97321,833,901.01
  投资活动现金流入小计526,467,963.63471,008,667.12749,432,232.48372,984,859.88
  购建固定资产、无形资产和其他长期资产支付的现金29,547,965.454,563,256.83101,126,692.0455,792,032.89
  投资支付的现金--15,000,00010,000,000
  支付其他与投资活动有关的现金524,809,000493,009,000808,662,500413,614,851.01
  投资活动现金流出小计554,356,965.45497,572,256.83924,789,192.04479,406,883.9
  投资活动产生的现金流量净额-27,889,001.82-26,563,589.71-175,356,959.56-106,422,024.02
三、筹资活动产生的现金流量:
  吸收投资收到的现金--4,700,000-
  筹资活动现金流入平衡项目--0-
  筹资活动现金流入小计--4,700,000-
  分配股利、利润或偿付利息支付的现金--10,587,354.3510,587,354.35
  筹资活动现金流出平衡项目--00
  筹资活动现金流出小计--10,587,354.3510,587,354.35
  筹资活动产生的现金流量净额平衡项目--00
  筹资活动产生的现金流量净额---5,887,354.35-10,587,354.35
四、汇率变动对现金及现金等价物的影响-105,771.77-36,203.3368,603.89-261,946.79
五、现金及现金等价物净增加额1,347,126.43-15,916,028.39-44,901,763.82-11,810,087.37
  加:期初现金及现金等价物余额75,262,690.3175,262,690.31120,164,454.13120,164,454.13
  期末现金及现金等价物余额76,609,816.7459,346,661.9275,262,690.31108,354,366.76
补充资料:
  净利润45,755,010.5--76,874,137.69-
  资产减值准备1,143,047.16-1,324,236.93-
  固定资产和投资性房地产折旧22,807,516.02-42,774,425.64-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧22,807,516.02-42,774,425.64-
  无形资产摊销1,891,989.81-4,126,947.51-
  处置固定资产、无形资产和其他长期资产的损失-111,881.57---
  固定资产报废损失--48,624.87-
  公允价值变动损失-38,542,068.26-56,509,203.23-
  财务费用---6.42-
  投资损失-7,452,845.57-51,620,778.39-
  递延所得税5,902,576.36--19,342,454.26-
  其中:递延所得税资产减少-170,974.58-636,073.82-
    递延所得税负债增加6,073,550.94--19,978,528.08-
  存货的减少-1,524,844.08-22,359,302.56-
  经营性应收项目的减少3,609,797.82-14,709,258.34-
  经营性应付项目的增加-4,311,804.24-37,978,868.7-
  其他--388,086.35-
  现金的期末余额76,609,816.74-75,262,690.31-
  减:现金的期初余额75,262,690.31-120,164,454.13-
  现金及现金等价物的净增加额1,347,126.43--44,901,763.82-
公告日期2025-08-222025-04-242025-03-292024-10-25
审计意见(境内)标准无保留意见
TOP↑